Cargando…
Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma
AIMS: Based on the hypothesis that first-line chemoradiation followed by chemotherapy was superior for primary tumor and non-inferior for distant lesions compared to chemotherapy alone in synchronous unresectable distant metastases rectal adenocarcinoma, this study was designed to assess the efficac...
Autores principales: | Zhu, Ji, Lian, Peng, Liu, Fangqi, Xu, Ye, Xu, Junyan, Guan, Zuqing, Liang, Liping, Wang, Minghe, Cai, Sanjun, Zhang, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552710/ https://www.ncbi.nlm.nih.gov/pubmed/23295152 http://dx.doi.org/10.1186/1748-717X-8-10 |
Ejemplares similares
-
Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study
por: Zhu, Ji, et al.
Publicado: (2014) -
The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
por: Chen, Yikuan, et al.
Publicado: (2022) -
Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers
por: Peng, Junjie, et al.
Publicado: (2014) -
A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study
por: Liu, Lin-Lin, et al.
Publicado: (2021) -
The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)